TY - JOUR
T1 - Evaluation of preventive technologies in Germany
T2 - Case studies of mammography, prostate cancer screening, and fetal ultrasound
AU - Perleth, Matthias
AU - Busse, Reinhard
AU - Gibis, Bernhard
AU - Brand, Angela
PY - 2001/8/16
Y1 - 2001/8/16
N2 - Objective: In this article, three preventive strategies - mammography screening for breast cancer, PSA screening for prostate cancer, and routine ultrasound in normal pregnancy - are discussed in the context of German health care. Methods: Epidemiologic data and German studies evaluating different aspects of these preventive measures were identified and analyzed. Results: Only a few studies could be identified that investigate these preventive measures. Despite sufficient evidence, in part derived from a German study, there is not yet a mammography screening program. In contrast, ultrasound in pregnancy is offered routinely, although there are controversies regarding the benefit of this practice. PSA screening is not offered as part of the screening program for prostate cancer. However, PSA tests as well as mammographies are done in large numbers in German ambulatory care - a practice that could be considered wild or opportunistic screening. Conclusions: These case studies show that preventive programs and practices in Germany are not sufficiently based on sound evidence. The paucity of evaluation activities related to prevention in Germany is probably due to the low threshold to introduce new preventive programs into the German healthcare system in the past.
AB - Objective: In this article, three preventive strategies - mammography screening for breast cancer, PSA screening for prostate cancer, and routine ultrasound in normal pregnancy - are discussed in the context of German health care. Methods: Epidemiologic data and German studies evaluating different aspects of these preventive measures were identified and analyzed. Results: Only a few studies could be identified that investigate these preventive measures. Despite sufficient evidence, in part derived from a German study, there is not yet a mammography screening program. In contrast, ultrasound in pregnancy is offered routinely, although there are controversies regarding the benefit of this practice. PSA screening is not offered as part of the screening program for prostate cancer. However, PSA tests as well as mammographies are done in large numbers in German ambulatory care - a practice that could be considered wild or opportunistic screening. Conclusions: These case studies show that preventive programs and practices in Germany are not sufficiently based on sound evidence. The paucity of evaluation activities related to prevention in Germany is probably due to the low threshold to introduce new preventive programs into the German healthcare system in the past.
UR - http://www.scopus.com/inward/record.url?scp=0034906801&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034906801&partnerID=8YFLogxK
U2 - 10.1017/S0266462301106057
DO - 10.1017/S0266462301106057
M3 - Article
C2 - 11495377
AN - SCOPUS:0034906801
SN - 0266-4623
VL - 17
SP - 329
EP - 337
JO - International Journal of Technology Assessment in Health Care
JF - International Journal of Technology Assessment in Health Care
IS - 3
ER -